This is the authors' abstract. We don't add key points for this paper.
Identification of A Novel Mutation in RYR1 Gene in Malignant Hyperthermia-Like Patient's Family Members Malignant hyperthermia (MH) is a rare pharmacogenetic disorder with an autosomal dominant inheritance that presents as a hypermetabolic response in skeletal muscle to volatile anaesthetic (halothane, isoflurane, desflurane, sevoflurane) and the depolarising muscle relaxant succinil-choline and rarely to stresses such as vigorous exercise and heat. We investigated the relatives of an individual with suspected MH and found a novel mutation in RYR1 gene. The molecular analysis of RYR1 gene revealed a novel nucleotide substitution in exon 6 - G528T (Glu-176-Asp) in four family members of the patient. The in vitro contracture test (IVCT) according to the European Malignant Hyperthermia Group (EMHG) guidelines showed a MH susceptible phenotype in two tested family members.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kauliñš et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: